Primary coronary angioplasty in acute myocardial infarction: Is it possible to prevent postinfarction cardiac rupture?

Italian Heart Journal

Volumn 1, Issue 6, 2000, Pages 400-406

  Bartoletti, A ^a   Fantini, A ^a   Meucci, F ^a   Idini, R ^a   Abbondanti, A ^a   Mangialavori, G ^a   Margheri, M ^a   Vergassola, R ^a  

^a NONE   (Italy)

Author keywords

Cardiac rupture; Coronary angioplasty; Echocardiography; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CONTROLLED STUDY; FATALITY; FEMALE; HEART INFARCTION; HEART RUPTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMPARATIVE STUDY; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HEART RUPTURE, POST-INFARCTION; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0033830512     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Les ruptures parietales et septales au cours des infarctus myocardiques
2. Analyse de 153 cas de rupture du myocarde apres l'infarctus aigu du myocarde
3. Cardiac rupture - Challenge in diagnosis and management
4. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis
5. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1
6. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: Observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study
7. Effect of nitrates on the frequency of left ventricular free wall rupture complicating acute myocardial infarction: A case-controlled study
8. Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
9. Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study
10. Rupture of the myocardium. Occurrence and risk factors
11. Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of Coronary Care Units
12. Rottura della parete libera del ventricolo sinistro in corso di infarto miocardico: Incidenza, presentazione clinica, evoluzione
13. La rottura di cuore quale complicanza dell'infarto miocardico in fase acuta. Contributo casistico ed evoluzione clinica dei sopravvissuti
14. The spectrum of death after myocardial infarction: A necropsy study
15. Factors influencing rupture of the heart after myocardial infarction
16. The pathogenesis of spontaneous cardiac rupture
17. Myocardial rupture after myocardial infarction is related to the perfusion status of the infarct-related coronary artery
18. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
19. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
20. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
21. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
22. Trattamento sistematico dell'infarto miocardico acuto con angioplastica primaria. Risultati clinici e angiografici precoci e a sei mesi
23. Task Force on Standardization of Clinical Nomenclature: Nomenclature and criteria for diagnosis of ischemic heart disease
24. A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction
25. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
26. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
27. ACC/AHA guidelines for coronary angiography: Executive summary and recommendations
28. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - The strategy of choice
29. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase
30. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence Randomized Elective Stenting in acute Coronary Occlusions (FRESCO) trial
31. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
32. Pericardial effusion in the course of myocardial infarction: Incidence, natural history and clinical relevance
33. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: Sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria
34. Diagnostic criteria and management of subacute ventricular free wall rupture complicating acute myocardial infarction
35. Acute myocardial infarction: Complications
36. La rottura esterna dell'area necrotica in corso di infarto miocardico: Rassegnazione o necessita di ripensamento?
37. Spontaneous rupture of the heart: A clinical pathologic study based on 22 unpublished cases and 632 from the literature
38. Pathogenesis of cardiac rupture
39. Rupture of the heart. A critical analysis of 47 consecutive autopsy cases
40. Cardiac rupture during myocardial infarction. A review of 44 cases
41. Les ruptures du coeur a la phase aigue de l'infarctus du myocarde
42. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials
43. Analisi delle cause di morte intraospedaliera
44. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction
45. The early risk of thrombolytic therapy for acute myocardial infarction: Incidence, mechanisms and possible prevention
46. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?
47. The effect of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction
48. Effect on collagen metabolism of thrombolytic therapy with tissue-plasminogen activator. A randomized, placebo-controlled study
49. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator
50. Massive hemorrhagic myocardial infarction after coronary thrombolysis
51. Cardiac tamponade early after thrombolysis for acute myocardial infarction: A rare but not reported hemorrhagic complication
52. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction
53. Immediate coronary angioplasty versus intravenous streptokinase in adult myocardial infarction: Left ventricular ejection fraction, hospital mortality and reinfarction
54. Long-term outcome after primary angioplasty: Report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial
55. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction
56. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction
57. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the 'real world': One-year results from a nationwide French survey
58. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients
59. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials
60. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: A 3-year experience
61. Timing and mechanism of in-hospital and late death after primary coronary angioplasty during acute myocardial infarction
62. Timing and mechanism of death determined clinically after primary angioplasty for acute myocardial infarction
63. Subacute heart rupture following myocardial infarction. Clinical features of a correctable condition
64. Reliability of electromechanical dissociation in the diagnosis of left ventricular free wall rupture in acute myocardial infarction
65. Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction
66. Abciximab facilitates the rate and extent of thrombolysis. Results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial
67. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. PACT Investigators. Plasminogen-activator Angioplasty Compatibility Trial